Alterity Therapeutics Statistics
NASDAQ: ATHEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.10-0.22 (-6.63%)
Market open · Delayed 15 min · as of Oct 8, 11:56 AM ET
Alterity Therapeutics by the numbers
Alterity Therapeutics has a market capitalization of $56.4 million based on 18.21M shares outstanding. With trailing EPS of $-0.90, Alterity Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.2% below its 50-day average and 23.3% below its 200-day average.
Average daily trading volume is 16.33K shares, or about $50,620 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATHE valuation vs. peer median
| Metric | ATHE | Peer median | Difference |
|---|---|---|---|
| Market cap | $56.45M | $60.67M | -7% |
| Avg. volume | 16.33K | 434.62K | -96% |
Peer median across 8 companies: PLRX, GOSS, APLM, RNXT, IBIO, MREO, XLO, BOLD.
Valuation
- Market cap
- $56.45M
- EPS (TTM)
- $-0.90
- Shares outstanding
- 18.21M
Price and trading
- Previous close
- 3.32
- Open
- 3.15
- Day range
- 3.10 – 3.24
- 52-week range
- 2.66 – 5.89
- 52-week change
- -22.43%
- Beta
- —
- Volume
- 24.38K
- Average volume
- 16.33K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2025
Additional statistics
- Market Cap
- 56.45M
- Forward Pe
- -3.24
- Eps
- -0.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.89
- Week52 Low
- 2.66
- Avg Volume
- 16,329.00
- Shares Outstanding
- 18.21M
- Ma50
- 4.20
- Ma200
- 4.04
- Earnings Date
- Aug 4, 2025
- Pct From52w High
- -47.37%
- Pct From52w Low
- 16.54%